World Investment Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.7M Sell
33,689
-5,206
-13% -$436K 0.04% 401
2026
Q1
$3.11M Sell
38,895
-1,091
-3% -$89.9K 0.05% 369
2025
Q4
$3.41M Buy
39,986
+3,877
+11% +$318K 0.06% 342
2025
Q3
$2.81M Sell
36,109
-25,029
-41% -$1.96M 0.06% 336
2025
Q2
$4.78M Sell
61,138
-11,426
-16% -$852K 0.11% 220
2025
Q1
$5.26M Buy
72,564
+4,016
+6% +$287K 0.14% 180
2024
Q4
$5.07M Sell
68,548
-3,729
-5% -$261K 0.14% 170
2024
Q3
$4.77M Buy
72,277
+68,172
+1,661% +$4.95M 0.15% 163
2024
Q2
$379K Sell
4,105
-96
-2% -$8.5K 0.02% 449
2024
Q1
$401K Buy
+4,201
New +$353K 0.06% 257

Other funds holding EW

World Investment Advisors's EW Position: Q2 2026 in Review

World Investment Advisors reduced its Edwards Lifesciences (EW) stake by 13% in Q2 2026, selling an estimated $436K and leaving 33,689 shares worth $2.7M. The position accounts for 0.04% of the portfolio, ranked #401.

World Investment Advisors first reported a position in EW in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.26M in Q1 2025. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • World Investment Advisors held 33,689 shares of Edwards Lifesciences worth $2.7M as of Q2 2026.
  • World Investment Advisors sold 5,206 Edwards Lifesciences shares in Q2 2026, an estimated $436K.
  • Edwards Lifesciences made up 0.04% of World Investment Advisors's portfolio in Q2 2026, its #401 holding.
  • World Investment Advisors first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 10 quarters since.
  • World Investment Advisors's Edwards Lifesciences position peaked at $5.26M in Q1 2025.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.